Navigation Links
Textile Company PurThread Technologies Opens Headquarters in Durham, North Carolina and Hires New Senior Staff
Date:6/26/2012

DURHAM, N.C., June 26, 2012 /PRNewswire/ --  A new medical textile company has established its headquarters in Durham, North Carolina. PurThread Technologies, a development-stage biotech firm dedicated to using antimicrobial textile technology to help hospitals reduce the bioburden in the patient environment, chose Durham for its access to key textile and medical industry players.  The new PurThread headquarters also brings with it two new senior staff; Dr. Stanley D. Chamberlain as the new Chief Scientific Officer and Michael Weldon as the new Senior Director of Sales for the Northeast Region.  The company's founder and current Chief Scientific Officer, Stephen Foss will now serve as PurThread's Chief Technology Officer.

"Durham is a great place for us," said Bill O'Neill Vice President of Infection Control Applications at PurThread Technologies. "Here we are surrounded by the medical and textile industry ecosystem and closer to many current and potential partners. We are thrilled to call Durham home and look forward to supporting the economy here and throughout the Carolinas."

PurThread develops textiles, such as privacy curtains, linens and hospital garments that help to reduce the level of bioburden on hard-to-clean soft surfaces in healthcare environments, as well as in military and consumer applications. The textiles employ the antimicrobial effects of silver, copper and other elements in a proprietary Complex Element Compound to create a continuously active and soft textile. Studies have shown that reducing the level of bioburden within the patient environment can lead to a reduction in healthcare associated infections (HAIs). In the US, 100,000 people die each year from HAIs making them the fourth largest cause of mortality according to the Centers for Disease Control and Prevention (CDC).

PurThread Management Team Additions

Chief Scientific Officer
Stanley D. Chamberlain

Stanley D. Chamberlain, Ph.D. served most recently as Vice President of Chemistry at Inhibitex. Since early 2008, he was responsible for the R&D efforts of the anti-HCV compound INX-08189. Prior to Inhibitex, Chamberlain was Senior Group Manager in Medicinal Chemistry Oncology at Glaxo SmithKline in Research Triangle Park.  Additionally, Dr. Chamberlain was a Group Leader at Glaxo Wellcome and held Senior Scientist positions at Burroughs Wellcome.

Senior Director of Sales
Michael Weldon

Michael Weldon brings a rich 18-year history in healthcare sales to PurThread, as its new Senior Director of Sales. Before joining the company, he was Senior Director, Market Management at VHA New England, a group purchasing organization for hospitals. Prior to VHA, he was Senior Consultant at Andersen Consulting and Operations Manager at J.D. Cahill Company.

About PurThread Technologies, Inc.

PurThread Technologies, Inc., an emerging leader in antimicrobial textile technology research, is dedicated to developing continuously active soft surfaces that show a measureable difference in  reducing the bioburden in clinical patient environments. PurThread supports current healthcare infection prevention and hand hygiene efforts by providing an additional layer of protection between patients and the freshly washed hands of healthcare workers. PurThread products range from healthcare textiles, such as privacy curtains, sheets, scrubs, blankets, and lab coats, as well as a range of products for other markets such as the military, emergency first responders and performance athletic wear. For more information on PurThread Technologies, Inc., please visit www.PurThread.com.

Media Contact:

Technica Communications
Lisa Ann Pinkerton
408-806-9626
Lisaann@technicacommunications.com


'/>"/>
SOURCE PurThread Technologies
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. GeneTex Antibody Company to Launch New Line of Primary Antibodies for the Study of Spindle Assembly
2. Monsanto Declared Worst Company of 2011 by NaturalSociety
3. Fox Insurance Company Awarded $3.3 Million in Arbitration Against Former Pharmacy Benefit Manager
4. Oxford Finance Provides $15 Million Senior Secured Credit Facility to Private Equity Backed Healthcare Services Company
5. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
6. Meaningful Use Stage Two: The Advisory Board Company Helps Hospitals Set Strategy
7. Aneesh Chopra to Serve as Senior Advisor to The Advisory Board Company
8. Regado Biosciences, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference in Boston, MA
9. Incline Therapeutics to Present at the Cowen and Company 32nd Annual Health Care Conference
10. Receptos to Present at the Cowen and Company 32nd Annual Health Care Conference
11. Nycomed, a Takeda Company, Launches Omnaris® Nasal Spray in the UAE for the Treatment of Allergic Rhinitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... SPRING, Md. , June 23, 2016 A ... collected from the crime scene to track the criminal down. ... and the U.S. Food and Drug Administration (FDA) uses DNA ... Sound far-fetched? It,s not. The ... genome sequencing to support investigations of foodborne illnesses. Put as ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, ... microbial test has received AOAC Research Institute approval 061601. , “This is another ... year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
Breaking Biology Technology:
(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... project, for the , Supply and Delivery of ... Infrastructure , to Decatur , ... Management Solutions. Numerous renowned international vendors participated in the tendering ... selected for the most compliant and innovative solution. The contract ...
(Date:6/1/2016)... -- Favorable Government Initiatives Coupled With Implementation ... to Boost Global Biometrics System Market Through 2021  ... " Global Biometrics Market By Type, By End ... - 2021", the global biometrics market is projected to ... growing security concerns across various end use sectors such ...
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
Breaking Biology News(10 mins):